...
首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Acid-labile pHPMA modification of four-arm oligoaminoamide pDNA polyplexes balances shielding and gene transfer activity in vitro and in vivo
【24h】

Acid-labile pHPMA modification of four-arm oligoaminoamide pDNA polyplexes balances shielding and gene transfer activity in vitro and in vivo

机译:对四臂寡氨基酰胺pDNA复合物的酸不稳定pHPMA修饰平衡了体内外的屏蔽和基因转移活性

获取原文
获取原文并翻译 | 示例

摘要

We report novel pH-reversibly surface-shielded polyplexes with enhanced gene transfer activity upon systemic administration. A four-arm-structured sequence-defined cationic oligomer KK[HK[(H-Sph-K)(3)HC](2)](2) was designed and synthesized on solid-phase, containing additional lysine residues not only for improved pDNA polyplex stability, but also providing attachment points for subsequent polyplex functionalization with amine-reactive shielding polymers. Herein, the surface of polyplexes was shielded with hydrophilic polymers, monovalent PEG or monovalent and multivalent pHPMA, optionally attached to the polyplex via the acid-labile linker AzMMMan. Overall, surface modification with PEG or pHPMA resulted in a decrease in the zeta potential of polyplexes, consistent with the degree of surface shielding. At pH 6.0, only polyplexes modified via the acid-labile linkage showed an increase in zeta potential, consistent with a "deshielding" in acidic environment, expected as beneficial for endosomal escape. Shielding was more efficient for multivalent pHPMA (20 kDa, 30 kDa) as compared to monovalent pHPMA (10 kDa, 20 kDa, 30 kDa) or PEG (5 kDa). In vitro transfection studies revealed higher gene expression by the polyplexes with the acid-labile shield as compared to their irreversibly shielded counterparts. Intravenous administration of AzMMMan-pHPMA modified polyplexes in an in vivo tumor mouse model mediated enhanced gene expression in the subcutaneous tumor and reduced undesirable expression in the liver. (C) 2016 Elsevier B.V. All rights reserved.
机译:我们报告新型的pH可逆性表面屏蔽的复合物,全身给药后具有增强的基因转移活性。设计并合成了固相合成的四臂结构序列定义的阳离子低聚物KK [HK [(H-Sph-K)(3)HC](2)](2),不仅包含赖氨酸残基,而且还包含改进了pDNA多元复合物的稳定性,但也为随后用胺反应性屏蔽聚合物进行的多元复合物功能化提供了连接点。在此,用亲水性聚合物,单价PEG或单价和多价pHPMA屏蔽多聚物的表面,该聚合物任选通过酸不稳定的连接基AzMMMan连接到多聚物上。总体而言,用PEG或pHPMA进行的表面改性导致多聚体的Zeta电位降低,这与表面屏蔽程度一致。在pH 6.0时,只有通过酸不稳定键修饰的多链体显示出ζ电位的增加,这与酸性环境中的“去屏蔽”相一致,预计对内体逃逸有益。与单价pHPMA(10 kDa,20 kDa,30 kDa)或PEG(5 kDa)相比,多价pHPMA(20 kDa,30 kDa)的屏蔽效率更高。体外转染研究表明,与酸不可逆的屏蔽物相比,带有酸不稳定屏蔽物的多链体具有更高的基因表达。在体内肿瘤小鼠模型中静脉内注射AzMMMan-pHPMA修饰的复合物介导皮下肿瘤中基因表达增强,并减少肝脏中不良表达。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号